Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
02 January 2019Website:
http://apyxmedical.comNext earnings report:
08 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 20:06:32 GMTDividend
Analysts recommendations
Institutional Ownership
APYX Latest News
CLEARWATER, Fla., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Apyx® Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today announced that financial results for the third quarter of fiscal year 2024 will be released before the market opens on Friday, November 8th.
Apyx (APYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Apyx Medical Corporation (NASDAQ:APYX ) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Charles Goodwin - President, Chief Executive Officer & Director Matthew Hill - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Frank Takkinen - Lake Street Capitals George Sellers - Stephens Inc Operator Hello, and welcome, ladies and gentlemen, to the Second Quarter of Fiscal Year 2024 Earnings Conference Call for Apyx Medical Corporation. At this time all participants have been placed in a listen-only more.
Apyx Medical (APYX) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.11 per share a year ago.
Renuvion is the only device FDA-cleared for contracting subcutaneous tissue CLEARWATER, Fla. , June 26, 2024 /PRNewswire/ -- Apyx® Medical Corporation (NASDAQ: APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced the launch of the "Renewing Lives" campaign, a nationwide, life-changing give-back program that will provide Renuvion treatments to people who can most benefit from this advanced medical technology.
Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript
Apyx Medical (APYX) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.17 per share a year ago.
Apyx Medical Corporation (NASDAQ:APYX ) Q3 2023 Earnings Conference Call November 9, 2023 8:00 AM ET Company Participants Charles Goodwin - President & CEO Tara Semb - CFO Conference Call Participants Frank Takkinen - Lake Street Capital Markets Matthew O'Brien - Piper Sandler Matt Hewitt - Craig-Hallum George Sellers - Stephens Dave Turkaly - JMP Securities Operator Please stand by. Hello, and welcome, ladies and gentlemen, to the Third Quarter of Fiscal Year 2023 Earnings Conference Call for Apyx Medical Corporation.
Here is how Apyx Medical (APYX) and CymaBay Therapeutics Inc. (CBAY) have performed compared to their sector so far this year.
Apyx Medical Corporation (NASDAQ:APYX ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Charles Goodwin - President & CEO Tara Semb - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group George Sellers - Stephens Frank Takkinen - Lake Street Capital Markets Operator Hello, and welcome, ladies and gentlemen, to the Second Quarter of Fiscal 2023 Earnings Conference Call for Apyx Medical Corporation. At this time, all participants have been placed in a listen-only mode.
What type of business is Apyx Medical?
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
What sector is Apyx Medical in?
Apyx Medical is in the Healthcare sector
What industry is Apyx Medical in?
Apyx Medical is in the Medical Devices industry
What country is Apyx Medical from?
Apyx Medical is headquartered in United States
When did Apyx Medical go public?
Apyx Medical initial public offering (IPO) was on 02 January 2019
What is Apyx Medical website?
https://apyxmedical.com
Is Apyx Medical in the S&P 500?
No, Apyx Medical is not included in the S&P 500 index
Is Apyx Medical in the NASDAQ 100?
No, Apyx Medical is not included in the NASDAQ 100 index
Is Apyx Medical in the Dow Jones?
No, Apyx Medical is not included in the Dow Jones index
When was Apyx Medical the previous earnings report?
No data
When does Apyx Medical earnings report?
The next expected earnings date for Apyx Medical is 08 November 2024